Article Information
History
- July 19, 2020.
Article Versions
- Version 1 (July 8, 2020 - 08:24).
- Version 2 (July 9, 2020 - 10:55).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Dimitris Bertsimas, PhD1,2,#,
- Galit Lukin, MSc2,
- Luca Mingardi, BSc1,2,*,
- Omid Nohadani, PhD3,
- Agni Orfanoudaki, MSc2,*,
- Bartolomeo Stellato, PhD1,2,*,
- Holly Wiberg, MSc2,*,
- Sara Gonzalez-Garcia, MSc4,
- Carlos Luis Parra-Calderón, MSc4,
- The Hellenic COVID-19 Study Group,
- Kenneth Robinson, MD5,
- Michelle Schneider, RN5,
- Barry Stein, MD5,
- Alberto Estirado, BSc6,
- Lia a Beccara, MD7,
- Rosario Canino, MD7,
- Martina Dal Bello, PhD8,
- Federica Pezzetti, MD7 and
- Angelo Pan, MD7
- 1Sloan School of Management, Massachusetts Institute of Technology, MA, USA
- 2Operations Research Center, Massachusetts Institute of Technology, MA, USA
- 3Benefits Science Technologies, Boston, MA, USA
- 4Institute of Biomedicine of Seville (IBIS) / Virgen del Rocío University Hospital / CSIC / University of Seville, Seville, Spain
- 5Hartford HealthCare, CT, USA
- 6HM Hospitals, Spain
- 7Azienda Socio-Sanitaria Territoriale di Cremona, Italy
- 8Physics of Living Systems, Massachusetts Institute of Technology, MA, USA
- ↵#Corresponding Author:
Dimitris Bertsimas, Sloan School of Management, Massachusetts Institute of Technology, MA, USA, Email: dbertsim{at}mit.edu
↵* These authors contributed equally to this work.
Posted July 19, 2020.
